logo
Chelmsford Star co-op merges with larger regional group

Chelmsford Star co-op merges with larger regional group

BBC News07-08-2025
An independent co-operative group of shops has merged with the larger regional Co-op company.Chelmsford Star Co-operative Society was founded 158 years ago and runs 34 convenience stores, an off-licence, nine funeral branches and two department stores.Its most recent annual report showed its gross profit dropped year-on-year by 5.5%.Barry Wood, chief executive of Chelmsford Star, said the decision to merge with the larger Central Co-op was "rooted in a desire to protect jobs and ensure long-term sustainability".
In its annual report to shareholders in January 2025, Chelmsford Star said: "The retail landscape continues to evolve post-pandemic for a further consecutive year."The year has presented challenges, with the continuing cost of living crisis affecting us all."It also pointed to "ongoing conflicts" affecting the cost of energy and commodities.Gross takings dropped from £108m to £101m year-on-year, and gross profit decreased from £25,673 to £24,263.Chelmsford Star is due to transfer to Central Co-op - which trades across the East Midlands and East Anglia - on 15 September.However, the Chelmsford Star trading name will continue to be used locally.Mr Moore added: "We're joining with a like-minded co-operative that shares our values and will help carry forward the legacy of Chelmsford Star co-operative for years to come."Debbie Robinson, chief executive of Central Co-op, said: "We're committed to working closely with Chelmsford Star members and colleagues to ensure a smooth and respectful transition - one that secures long-term sustainability and allows us to continue making a real difference in the communities we serve."
Follow Essex news on BBC Sounds, Facebook, Instagram and X.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's Bio-Thera Solutions licenses its arthritis drug to  Germany's STADA
China's Bio-Thera Solutions licenses its arthritis drug to  Germany's STADA

Reuters

time8 minutes ago

  • Reuters

China's Bio-Thera Solutions licenses its arthritis drug to Germany's STADA

HONG KONG, Aug 21 (Reuters) - China's Bio-Thera Solutions ( opens new tab said on Thursday it has granted Germany's STADA Arzneimittel commercialisation rights for its arthritis drug BAT1806, opens new tab in the EU, UK, Switzerland, certain Middle East and North Africa regions, and certain members of the Commonwealth of Independent States. Upfront payment and milestone payments will total up to 136 million euros ($158.34 million), including an 8.5 million euro down payment, milestone payments up to 127.5 million euros, and a double-digit percentage of net sales as revenue sharing, the Shanghai-listed firm said in a stock exchange filing, opens new tab. ($1 = 0.8589 euros)

China's Bio-Thera Solutions signs licensing deal with Germany's STADA for BAT1806 injection
China's Bio-Thera Solutions signs licensing deal with Germany's STADA for BAT1806 injection

Reuters

time38 minutes ago

  • Reuters

China's Bio-Thera Solutions signs licensing deal with Germany's STADA for BAT1806 injection

HONG KONG, Aug 21 (Reuters) - China's Bio-Thera Solutions ( opens new tab on Thursday said it has signed an agreement granting Germany's STADA Arzneimittel commercialisation rights for its BAT1806 injection in the EU, UK, Switzerland, certain Middle East and North Africa regions, and certain members of the Commonwealth of Independent States. Upfront payment and milestone payments will total up to 136 million euros ($158.34 million), including an 8.5 million euro down payment, milestone payments up to 127.5 million euros, and a double-digit percentage of net sales as revenue sharing, the Shanghai-listed firm said in a stock exchange filing, opens new tab. ($1 = 0.8589 euros)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store